GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Genesystem Co Ltd (XKRX:363250) » Definitions » Net Margin %

Genesystem Co (XKRX:363250) Net Margin % : -1,607.61% (As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Genesystem Co Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. Genesystem Co's Net Income for the three months ended in Mar. 2024 was ₩-2,173.6 Mil. Genesystem Co's Revenue for the three months ended in Mar. 2024 was ₩135.2 Mil. Therefore, Genesystem Co's net margin for the quarter that ended in Mar. 2024 was -1,607.61%.

The historical rank and industry rank for Genesystem Co's Net Margin % or its related term are showing as below:

XKRX:363250' s Net Margin % Range Over the Past 10 Years
Min: -1413.28   Med: -246.26   Max: 26.83
Current: -1413.28


XKRX:363250's Net Margin % is ranked worse than
92.31% of 221 companies
in the Medical Diagnostics & Research industry
Industry Median: -12.7 vs XKRX:363250: -1413.28

Genesystem Co Net Margin % Historical Data

The historical data trend for Genesystem Co's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genesystem Co Net Margin % Chart

Genesystem Co Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Net Margin %
-356.08 -16.77 26.83 -246.26 -882.41

Genesystem Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -461.62 -1,267.87 -1,119.62 -2,258.65 -1,607.61

Competitive Comparison of Genesystem Co's Net Margin %

For the Diagnostics & Research subindustry, Genesystem Co's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Genesystem Co's Net Margin % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Genesystem Co's Net Margin % distribution charts can be found below:

* The bar in red indicates where Genesystem Co's Net Margin % falls into.



Genesystem Co Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Genesystem Co's Net Margin for the fiscal year that ended in Dec. 2023 is calculated as

Net Margin=Net Income (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=-7915.456/897.028
=-882.41 %

Genesystem Co's Net Margin for the quarter that ended in Mar. 2024 is calculated as

Net Margin=Net Income (Q: Mar. 2024 )/Revenue (Q: Mar. 2024 )
=-2173.647/135.21
=-1,607.61 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Genesystem Co  (XKRX:363250) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


Genesystem Co Net Margin % Related Terms

Thank you for viewing the detailed overview of Genesystem Co's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Genesystem Co (XKRX:363250) Business Description

Traded in Other Exchanges
N/A
Address
200-9, Techno 2-ro, Yuseong-gu, Daejeon, KOR, 34028
Genesystem Co Ltd is a biotech engineering company specializing in molecular testing solutions that target on-site testing needs. It develops and markets state-of-the-art PCR platforms as well as related reagents and biochip products designed to enhance the health of human societies and improve the quality of human life.

Genesystem Co (XKRX:363250) Headlines

No Headlines